Is COVID-19 on the verge of ending?

In a current letter to the Journal of Medical Virology, researchers discover the modifications arising in extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2) over time. Since SARS-CoV-2 first emerged on the finish of December 2019, it has contaminated greater than 472 million worldwide and brought about over 6.09million deaths.

Study: Are we moving towards ending SARS-CoV-2? Image Credit: FOTOGRIN /

Research: Are we shifting in the direction of ending SARS-CoV-2? Picture Credit score: FOTOGRIN /

Whereas in developed nations, mass vaccination packages have helped scale back the injury attributable to the coronavirus illness 2019 (COVID-19), thousands and thousands of people have but to obtain a vaccine. Moreover, the emergence of recent SARS-CoV-2 variants which are able to evading each pure and vaccine-induced immunity additionally threatens the efficacy of present COVID-19 vaccines. Understanding the character of the modifications which have occurred because the starting of the pandemic may assist stop extra deaths sooner or later.

A quick historical past of COVID-19

Regardless of native and worldwide efforts to halt the transmission of SARS-CoV-2, this virus rapidly unfold to the remainder of the world, with critical epidemics initially reported in neighboring international locations to China and Europe earlier than in the end being detected in virtually each nation around the globe.

Coronaviruses are separated into 4 genera; nonetheless, solely alphacoronaviruses and betacoronaviruses are able to infecting people. SARS-CoV-2 shares about 89% sequence id with different human coronaviruses, and 89-96% homology with coronavirus’ present in bats, thus suggesting a zoonotic origin. Media shops quickly recognized this element, which is commonly misreported as a direct soar from bats to people. Nevertheless, nearer evaluation has revealed a number of different potential sources of this virus, together with a minimum of one intermediate host that transferred SARS-CoV-2 from bats to people.

SARS-CoV-2 mutations and variants

The nonstructural protein 14 (nsp14)-exon encodes a ribonucleic acid (RNA) proofreading exonuclease designed to make sure the constancy of the genetic copy of SARS-CoV-2. Regardless of this, important mutations in SARS-CoV-2 have accrued over the course of the pandemic.

Probably the most notable SARS-CoV-2 mutations to emerge are these affecting the spike protein, which is answerable for cell entry and membrane fusion. In truth, the primary official variant of SARS-CoV-2 carried a mutation at D614G on the spike protein, which later turned prevalent worldwide.

Since then, a number of SARS-CoV-2 variants together with the Alpha (B.1.1.7), Beta (B.1.351), Gamma (P1), Delta (B.1.617.2), and Omicron (B.1.1.529) variants.

Mutations within the spike protein can enable SARS-CoV-2 to flee immune detection, thus permitting an infection regardless of prior vaccination. So far, the SARS-CoV-2 Omicron variant is especially identified for its means to trigger breakthrough infections.

A number of medicine have just lately been developed that may shield people, regardless of fixed mutations. Most of those therapeutics goal the primary viral protease Mpro/3CL protease or RNA-dependant RNA polymerase (RdRp), that are conserved throughout all variants. As immunity towards SARS-CoV-2 fades comparatively quickly, medicine reminiscent of remdesivir, molnupiravir, and PAXLOVID may assist present an alternative choice to fixed vaccine boosters.

Elevated transmissibility and lowered severity of Omicron an infection

Some mutations, reminiscent of in these throughout the regulatory area of the nucleocapsid genes open studying body 9b (Orf9b) and Orf6, can result in greater expression. For these explicit genes, this delays the host immune response, thereby growing viral health.

Particularly, the Omicron variant consists of a excessive variety of mutations which have contributed to its elevated transmissibility. Furthermore, the Omicron variant binds to the angiotensin-converting enzyme 2 (ACE2) receptor with 44% extra affinity than the wild-type pressure.

Nevertheless, different Omicron mutations seem to scale back the severity of an infection with this variant as soon as contained in the host cell. In truth, the Omicron variant exhibits considerably lowered viral hundreds within the human airway than different cells, whereas lowered processing of the spike protein seems to considerably scale back cell-to-cell transmission. The Omicron variant additionally seems to be extra susceptible to temperature-based decay as in comparison with different variants.


The lowered severity of the Omicron variant, in addition to its rise to dominance in a number of nations, may counsel that this virus could have acquired these mutations in Africa, the place it first rose to prominence, particularly as many African nations have decrease ranges of vaccination. Different theories surmise that SARS-CoV-2 could have skilled a number of further zoonotic occasions, whereby the virus acquired new mutations till transferring again to people.

The excessive transmissibility and low severity of the SARS-CoV-2 Omicron variant may enable it to behave as a pure vaccine dose; nonetheless, many different scientists don’t assist this. COVID-19 can nonetheless be lethal to aged and immunocompromised people; due to this fact, permitting it a big inhabitants to behave as a reservoir is prone to enable for brand new and doubtlessly extra harmful variants to come up.

Nevertheless, the lowered severity of Omicron may nonetheless present some hope, as any zoonotic ailments present considerably decrease severity over time as they adapt to their new hosts. It’s actually doable that SARS-CoV-2 may proceed down this path.

Journal reference:

  • Mishra, A. R., Nayak, D., and Byrareddy, S. N. (2022). Are we shifting in the direction of ending SARS-CoV-2? Journal of Medical Virology. doi:10.1002/jmv.27722.

#COVID19 #verge